SG Americas Securities’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80K Buy
+13,015
New +$71.5K ﹤0.01% 3156
2026
Q1
Sell
-10,731
Closed -$57K 3168
2025
Q4
$57K Buy
+10,731
New +$54K ﹤0.01% 3338
2025
Q3
Sell
-21,765
Closed -$124K 3350
2025
Q2
$124K Buy
+21,765
New +$124K ﹤0.01% 2537
2021
Q1
Sell
-488
Closed -$19K 3232
2020
Q4
$19K Buy
+488
New +$16.6K ﹤0.01% 3208
2020
Q3
Sell
-2,588
Closed -$189K 2638
2020
Q2
$189K Buy
2,588
+2,108
+439% +$146K ﹤0.01% 2901
2020
Q1
$25K Sell
480
-887
-65% -$59.2K ﹤0.01% 3276
2019
Q4
$112K Sell
1,367
-400
-23% -$28.2K ﹤0.01% 2889
2019
Q3
$100K Buy
1,767
+650
+58% +$48.7K ﹤0.01% 2728
2019
Q2
$134K Sell
1,117
-133
-11% -$22.3K ﹤0.01% 2650
2019
Q1
$230K Buy
1,250
+341
+38% +$61K ﹤0.01% 2471
2018
Q4
$162K Buy
909
+174
+24% +$37.9K ﹤0.01% 2491
2018
Q3
$235K Buy
+735
New +$261K ﹤0.01% 2486
2018
Q1
Sell
-551
Closed -$218K 3205
2017
Q4
$218K Buy
+551
New +$228K ﹤0.01% 2376
2016
Q2
Sell
-650
Closed -$42K 2569
2016
Q1
$42K Buy
+650
New +$43K ﹤0.01% 2779

Other funds holding ABEO

SG Americas Securities's ABEO Position: Q2 2026 in Review

SG Americas Securities opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 13,015 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #3156 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in ABEO as recently as Q4 2025.

SG Americas Securities first reported a position in ABEO in Q1 2016 and has held it in 14 quarters since. The position peaked at $235K in Q3 2018. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • SG Americas Securities held 13,015 shares of Abeona Therapeutics worth $80K as of Q2 2026.
  • Abeona Therapeutics was a new SG Americas Securities position in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3156 holding.
  • SG Americas Securities first reported a position in Abeona Therapeutics in Q1 2016 and has held it in 14 quarters since.
  • SG Americas Securities's Abeona Therapeutics position peaked at $235K in Q3 2018.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.